Skip to main content
SpringerLink
Log in

A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003; 56: 481–90.

    Article  CAS  Google Scholar 

  2. Moinzadeh P, Aberer E, Ahmadi-Simab K, et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis 2015; 74: 730–7.

    Article  CAS  Google Scholar 

  3. Alharbi S, Ahmad Z, Bookman AA, et al. Epidemiology and survival of systemic sclerosis-systemic lupus erythematosus overlap syndrome. J Rheumatol 2018; 45: 1406–10.

    Article  Google Scholar 

  4. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353: 2550–8.

    Article  CAS  Google Scholar 

  5. Symmons DP, Coppock JS, Bacon PA, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med 1988; 69: 927–37.

    CAS  PubMed  Google Scholar 

  6. Furie R, Petri MA, Strand V, et al. Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials. Lupus Science & Medicine 2014; 1: e000031.

    Article  Google Scholar 

  7. Stohl W, Hiepe F, Latinis KM, et al. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2328–37.

    Article  CAS  Google Scholar 

  8. Gordon JK, Martyanov V, Franks JM, et al. Belimumab for the treatment of early diffuse systemic sclerosis: results of a randomized, double-blind, placebo-controlled, pilot trial. Arthritis Rheumatol 2018; 70: 308–16.

    Article  CAS  Google Scholar 

  9. Jordan S, Distler JHW, Maurer B, et al. Rituximab study group effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis 2015; 74: 1188–94.

    Article  CAS  Google Scholar 

  10. Marzano AV, Tanzi C, Caputo R, Alessi E. Sclerodermic linear lupus panniculitis: report of two cases. Dermatology 2005; 210: 329–32.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Mami Hara, Mariko Ogawa-Momohara, Yoshinao Muro, Takuya Takeichi & Masashi Akiyama

Authors
  1. Mami Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariko Ogawa-Momohara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshinao Muro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takuya Takeichi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masashi Akiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshinao Muro.

Additional information

Disclosure

Conflicts of interest: none. Funding sources: none.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hara, M., Ogawa-Momohara, M., Muro, Y. et al. A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab. Eur J Dermatol 30, 615–617 (2020). https://doi.org/10.1684/ejd.2020.3868

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2020.3868

Search

Navigation